The Effect of Hinge Position and Hinge Width on Corneal Sensation and Dry Eye After IntraLase LASIK Procedure
NCT00803478 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2016-02-03
Summary
Corneal sensation is known to play a role in tear secretion. Decreased sensation leads to decreased tear production; and when bilateral, leads to a decreased blink rate as well. Dry eyes are a common side effect of LASIK. Incidence rates vary widely, but have been reported in as many as 59% of patients. And almost all patients have some transient dry eye symptoms immediately following LASIK.
Previous studies have looked at the effect of hinge position (superior vs. nasal) and hinge width on corneal sensation and dry eye after LASIK performed with a mechanical microkeratome. Corneal sensation was decreased and dry eye signs and symptoms increased immediately following LASIK in all eyes. These parameters then improved at all time periods between 1 week and 6 months post-operative. Loss of corneal sensation and dry eye signs and symptoms were greater in eyes with superior-hinge flap than nasal-hinge flap, and in eyes with narrower hinge flap rather than wider hinge flap IntraLase LASIK, using the IntraLase femtosecond laser rather than a mechanical microkeratome to cut the corneal flap, has become an increasingly popular procedure. It provides several advantages over mechanical microkeratomes, including reduced surgical complications, more predictable flap thickness, better astigmatic neutrality, decreased epithelial injury, and an ability to operate on a wider range of patients.
The investigators propose this study to evaluate the effect of flap hinge size and flap thickness in corneal flaps created with the IntraLase laser. The investigators would like to determine if there is a difference from the previously discussed results found when using the mechanical microkeratome. Also, with the increased ease of programming alternate hinge width or flap thickness with IntraLase, if the investigators find a significant difference with an alternate flap configuration, it might translate to a feasible change in clinical practice.
Conditions
- Myopia
Interventions
- PROCEDURE
-
LASIK
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
- Primary Completion
- 2008-09-30
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Artificial Tears on Ocular Biometry Parameters
NCT06656403 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
NCT00349440 ·Status: COMPLETED ·Phase: PHASE4
-
Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?
NCT02701764 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
NCT03815539 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation
NCT01128049 ·Status: COMPLETED ·Phase: NA
-
Impairment of Reading Ability in Dry Eye Patients
NCT01826812 ·Status: COMPLETED
-
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
NCT06860659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
Dry Eye Treatment With Artificial Tears
NCT02420834 ·Status: COMPLETED ·Phase: NA
-
Correlation of Different Signs for Assessment of Dry Eye Syndrome
NCT01753687 ·Status: COMPLETED ·Phase: NA
-
Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK
NCT06852105 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01240382 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics
NCT01450787 ·Status: TERMINATED
-
Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome
NCT02986750 ·Status: COMPLETED ·Phase: PHASE4
-
Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940 ·Status: COMPLETED
-
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
NCT03237936 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.
NCT06939959 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Tear Osmolarity Clinical Utility in Dry Eye Disease
NCT02417116 ·Status: COMPLETED ·Phase: NA
-
The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes
NCT06898853 ·Status: RECRUITING ·Phase: NA
-
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery
NCT06120348 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking
NCT05045053 ·Status: UNKNOWN ·Phase: PHASE4